Table 1 listed the LOXL2 expression data and clinical data for 374 HCC patients. We observed a significant association between LOXL2 expression and clinicopathological features, such as gender, T stage, and histologic grade (p < 0.05). The gene discussed is LOXL2; the disease is hepatocellular carcinoma.